the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

KL Sentral station redevelopment project to commence year-end – Loke

KUALA LUMPUR: Transport Minister Anthony Loke announced that the redevelopment of the Kuala Lumpur Sentral Station (KL Sentral) will begin later this year.

He said the Ministry of Transport will work together with Malaysian Resources Corporation Bhd (MRCB) on the said project.

“The station will undergo enhancements to make it more modern, efficient, and seamlessly connected to the surrounding areas.

“These enhancements will involve upgrades, redesigns, repurposing, and rebuilding efforts aimed at achieving a higher level of sophistication and modernity,” Loke told reporters after launching the opening of Menara Sentral RAC here today.

The minister also said that the redevelopment project had received Cabinet approval in principle last August to overhaul the KL Sentral Station through the Public Private Partnership initiative.

Project developer MRCB will undertake the redevelopment with a budget exceeding RM1.0 billion and this redevelopment will incur no cost to the government.

“Discussions with the Public Private Partnership Unit (Ukas), which comes under the Prime Minister’s Department, are underway,” he said.

Loke also outlined his plan for the KL Sentral area, detailing a comprehensive initiative to link all buildings, to improve public mobility and access.

“This interconnected network would enable smooth transitions between different points within the area, ultimately making navigation more convenient and effortless for the public,” he said.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings